Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10195 |
| Vaccine Name | ChAdOx1 MERS (MERS002) |
| Disease Name | MERS |
| Disease Classification | Respiratory |
| Virus Name | MERS-CoV |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Non-replicating viral vector |
| Vaccine Status | Phase 1 |
| Manufacturer | King Abdullah International Medical Research Center |
| Year of Manufacturing | 2020 |
| Manufacturing Country | Saudi Arabia |
| Age | 18 - 50 years |
| Dosage | NA |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | Eplication-deficient simian adenoviral vector expressing the spike protein of MERS Coronavirus |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | University of Oxford |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT04170829 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT04170829?cond=MERS-CoV&phase=0123&draw=2&rank=3 |
| Additional Links | NA |